Abstract
This JAMA Forum discusses artificial intelligence tools and the regulatory challenges for global regulatory bodies, including the US Food and Drug Administration, in creating new policies to ensure the safety and efficacy of these tools for patients.

This publication has 1 reference indexed in Scilit: